Evidence map›Paper›PMID 30342556›Full record

ArticleEuropean journal of medical research2018

Screening breast magnetic resonance imaging in women with hormone replacement therapy.

Feng Zhang, Qingjing Feng, Zhiyong Zhang, Yanjun Hu, Zhifeng Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of medical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Feng ZhangDepartment of Breast Surgery, Hangzhou Women's Hospital, Hangzhou, 310008, China. zhang3772@qq.com.ORCID http://orcid.org/0000-0002-3554-5807
Qingjing FengDepartment of Breast Surgery, Yiwu Maternity and Child Care Hospital, Yiwu, 322000, China.
Zhiyong ZhangDepartment of Breast Surgery, Hangzhou Women's Hospital, Hangzhou, 310008, China.
Yanjun HuReproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, 310006, China.
Zhifeng ZhangDepartment of Reproductive Endocrinology, Hangzhou Women's Hospital, Kunpeng Road 369, Hangzhou, 310008, China.
Hangzhou Women’s Hospital · CNWomen's Hospital, School of Medicine, Zhejiang University · CNYiwu Science and Technology Research Institute · CN

Funding

Hangzhou social development project 20170533B60
6 · The paper itself

Abstract

objectiveThe objective of this study was to compare the performance of screening mammography versus magnetic resonance imaging (MRI) in hormone replacement therapy (HRT) users.

methodsWe performed a retrospective review of 4628 women who had mammography or breast MRI screening from the beginning of HRT use at three institutions from April 2005 to December 2015. Information of demographics, number of biopsies performed and pathologic outcomes were collected. Sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) of screening mammography and MRI were compared.

resultsTotally 11,540 screening studies were collected, including 9580 mammography studies and 1960 MRI studies. Breast cancer was diagnosed in 26 patients. Of the 26 cancers, MRI detected 24 and mammography detected 15. For mammography, the sensitivity, specificity, PPV, and NPV were 57.7%, 99.1%, 14.6%, and 99.9%, respectively; for MRI, those values were 92%, 92.5%, 14.2%, and 99.9%, respectively. MRI screening was much more sensitive than mammography screening (p < 0.05, 92% vs 57.7%). There was no difference of specificity, PPV and NPV between two modalities.

conclusionsOur data showed that screening breast MRI may be a useful adjunct modality of mammography in HRT users.

Indexed as

Early Detection of CancerHormone Replacement TherapyAdultAgedBiopsyBreast NeoplasmsContrast MediaFemaleHumansMagnetic Resonance ImagingMammographyMass ScreeningMiddle AgedContrast MediaBreast cancerDuctal carcinomas in situHormone replacement therapyMagnetic resonance imagingMammography

Identifiers

PMID30342556
PMCPMC6195689
OpenAlexW2897145547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.